{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:52:41Z","timestamp":1778925161330,"version":"3.51.4"},"reference-count":80,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"\n Context.\u2014<\/jats:italic>\n Gallbladder cancer (GBC) is an aggressive neoplasia associated with late diagnosis, unsatisfactory treatment, and poor prognosis. Molecular mechanisms involved in GBC pathogenesis remain poorly understood. Connective tissue growth factor (CTGF) is thought to play a role in the pathologic processes and is overexpressed in several human cancers, including GBC. No information is available about CTGF expression in early stages of gallbladder carcinogenesis.\n <\/jats:p>\n \n Objective.\u2014<\/jats:italic>\n To evaluate the expression level of CTGF in benign and malignant lesions of gallbladder and its correlation with clinicopathologic features and GBC prognosis.\n <\/jats:p>\n \n Design.\u2014<\/jats:italic>\n Connective tissue growth factor protein was examined by immunohistochemistry on tissue microarrays containing tissue samples of chronic cholecystitis (n = 51), dysplasia (n = 15), and GBC (n = 169). The samples were scored according to intensity of staining as low\/absent and high CTGF expressers. Statistical analysis was performed using the \u03c7\n 2<\/jats:sup>\n test or Fisher exact probability test with a significance level of\n P<\/jats:italic>\n < .05. Survival analysis was assessed by the Kaplan-Meier method and the log-rank test.\n <\/jats:p>\n \n Results.\u2014<\/jats:italic>\n Connective tissue growth factor expression showed a progressive increase from chronic cholecystitis to dysplasia and then to early and advanced carcinoma. Immunohistochemical expression (score \u22652) was significantly higher in advanced tumors, in comparison with chronic cholecystitis (\n P<\/jats:italic>\n < .001) and dysplasia (\n P<\/jats:italic>\n = .03). High levels of CTGF expression correlated with better survival (\n P<\/jats:italic>\n = .04).\n <\/jats:p>\n \n Conclusions.\u2014<\/jats:italic>\n Our results suggest a role for CTGF in GBC progression and a positive association with better prognosis. In addition, they underscore the importance of considering the involvement of inflammation on GBC development.\n <\/jats:p>","DOI":"10.5858\/arpa.2011-0628-oa","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T13:59:27Z","timestamp":1359640767000},"page":"245-250","source":"Crossref","is-referenced-by-count":9,"title":["Connective Tissue Growth Factor Immunohistochemical Expression Is Associated With Gallbladder Cancer Progression"],"prefix":"10.5858","volume":"137","author":[{"given":"Patricia","family":"Garcia","sequence":"first","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Leal","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Alvarez","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Brebi","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ili","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Tapia","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Roa","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, School of Medicine, CEGIN-BIOREN, Universidad de La Frontera, Temuco, Chile (Drs Garcia, Leal, Brebi, Ili, Tapia, and Roa); the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Alvarez); and the Department of Pathology, School of Medicine, Pontificia Universidad Catolica de Chile (Drs Garcia and Roa)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"3","key":"i1543-2165-137-2-245-b01","series-title":"Eur J Surg Oncol","first-page":"306","article-title":"Gallbladder carcinoma","volume":"34","author":"Miller\n G,","year":"2008","unstructured":"Miller\n G, \n \n Jarnagin\n WR. \n \n Gallbladder carcinoma. Eur J Surg Oncol. 2008;34(3):306\u2013312."},{"issue":"7","key":"i1543-2165-137-2-245-b02","series-title":"Int J Cancer","first-page":"1591","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi\n G,","year":"2006;","unstructured":"Randi\n G, \n \n Franceschi\n S, \n \n La Vecchia\n C. \n \n Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591\u20131602."},{"issue":"8","key":"i1543-2165-137-2-245-b03","series-title":"Jpn J Clin Oncol","first-page":"992","article-title":"Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases","volume":"41","author":"Meng\n H,","year":"2011;","unstructured":"Meng\n H, \n \n Wang\n X, \n \n Fong\n Y, \n \n Wang\n ZH, \n \n Wang\n Y, \n \n Zhang\n ZT. \n \n Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992\u2013998."},{"issue":"2","key":"i1543-2165-137-2-245-b04","series-title":"World J Gastroenterol","first-page":"174","article-title":"Systematic review on the surgical treatment for T1 gallbladder cancer","volume":"17","author":"Lee\n SE,","year":"2011;","unstructured":"Lee\n SE, \n \n Jang\n JY, \n \n Lim\n CS, \n \n Kang\n MJ, \n \n Kim\n SW. \n \n Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17(2):174\u2013180."},{"issue":"105","key":"i1543-2165-137-2-245-b05","series-title":"Hepatogastroenterology","first-page":"14","article-title":"Optimal surgical treatment for patients with pT2 gallbladder cancer","volume":"58","author":"Harada\n K,","year":"2011;","unstructured":"Harada\n K, \n \n Ochiai\n T, \n \n Inoue\n K, \n et al\n . Optimal surgical treatment for patients with pT2 gallbladder cancer. Hepatogastroenterology. 2011;58(105):14\u201319."},{"issue":"4","key":"i1543-2165-137-2-245-b06","series-title":"Rev Med Chil","first-page":"387","article-title":"Morphological prognostic elements in gallbladder cancer [in Spanish]","volume":"130","author":"Roa\n I,","year":"2002;","unstructured":"Roa\n I, \n \n de Aretxabala\n X, \n \n Araya\n JC, \n et al\n . Morphological prognostic elements in gallbladder cancer [in Spanish]. Rev Med Chil. 2002;130(4):387\u2013395."},{"issue":"1","key":"i1543-2165-137-2-245-b07","series-title":"Eur J Surg Oncol","first-page":"80","article-title":"The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder","volume":"37","author":"Sergeant\n G,","year":"2011;","unstructured":"Sergeant\n G, \n \n Lerut\n E, \n \n Ectors\n N, \n \n Hendrickx\n T, \n \n Aerts\n R, \n \n Topal\n B. \n \n The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder. Eur J Surg Oncol. 2011;37(1):80\u201386."},{"issue":"8","key":"i1543-2165-137-2-245-b08","series-title":"Pathol Res Pract","first-page":"472","article-title":"Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma","volume":"207","author":"Liu\n DC,","year":"2011;","unstructured":"Liu\n DC, \n \n Yang\n ZL. \n \n Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol Res Pract. 2011;207(8):472\u2013478."},{"issue":"9","key":"i1543-2165-137-2-245-b09","series-title":"Clin Cancer Res","first-page":"3131","article-title":"Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival","volume":"10","author":"Varga\n M,","year":"2004;","unstructured":"Varga\n M, \n \n Obrist\n P, \n \n Schneeberger\n S, \n et al\n . Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res. 2004;10(9):3131\u20133136."},{"issue":"4","key":"i1543-2165-137-2-245-b10","series-title":"Int J Biochem Cell Biol","first-page":"771","article-title":"Functions and mechanisms of action of CCN matricellular proteins","volume":"41","author":"Chen\n CC,","year":"2009;","unstructured":"Chen\n CC, \n \n Lau\n LF. \n \n Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009;41(4):771\u2013783."},{"issue":"6","key":"i1543-2165-137-2-245-b11","series-title":"J Biomed Sci","first-page":"675","article-title":"Connective tissue growth factor (CTGF) and cancer progression","volume":"15","author":"Chu\n CY,","year":"2008;","unstructured":"Chu\n CY, \n \n Chang\n CC, \n \n Prakash\n E, \n \n Kuo\n ML. \n \n Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci. 2008;15(6):675\u2013685."},{"issue":"3","key":"i1543-2165-137-2-245-b12","series-title":"Cancer Res","first-page":"775","article-title":"The role of tumor cell\u2013derived connective tissue growth factor (CTGF\/CCN2) in pancreatic tumor growth","volume":"69","author":"Bennewith\n KL,","year":"2009;","unstructured":"Bennewith\n KL, \n \n Huang\n X, \n \n Ham\n CM, \n et al\n . The role of tumor cell\u2013derived connective tissue growth factor (CTGF\/CCN2) in pancreatic tumor growth. Cancer Res. 2009;69(3):775\u2013784."},{"issue":"1","key":"i1543-2165-137-2-245-b13","series-title":"Cancer Sci","first-page":"104","article-title":"Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-kappaB pathway","volume":"102","author":"Mao\n Z,","year":"2011;","unstructured":"Mao\n Z, \n \n Ma\n X, \n \n Rong\n Y, \n et al\n . Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-kappaB pathway. Cancer Sci. 2011;102(1):104\u2013110."},{"issue":"13","key":"i1543-2165-137-2-245-b14","series-title":"World J Gastroenterol","first-page":"2110","article-title":"Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer","volume":"14","author":"Liu\n LY,","year":"2008;","unstructured":"Liu\n LY, \n \n Han\n YC, \n \n Wu\n SH, \n \n Lv\n ZH. \n \n Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol. 2008;14(13):2110\u20132114."},{"issue":"1","key":"i1543-2165-137-2-245-b15","series-title":"Gastroenterology","first-page":"9","article-title":"Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer","volume":"128","author":"Lin\n BR,","year":"2005;","unstructured":"Lin\n BR, \n \n Chang\n CC, \n \n Che\n TF, \n et al\n . Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology. 2005;128(1):9\u201323."},{"issue":"5","key":"i1543-2165-137-2-245-b16","series-title":"J Natl Cancer Inst","first-page":"364","article-title":"Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis","volume":"96","author":"Chang\n CC,","year":"2004;","unstructured":"Chang\n CC, \n \n Shih\n JY, \n \n Jeng\n YM, \n et al\n . Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst. 2004;96(5):364\u2013375."},{"issue":"8","key":"i1543-2165-137-2-245-b17","series-title":"Mol Cancer Res","first-page":"591","article-title":"Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non\u2013small cell lung cancer cells","volume":"4","author":"Chien\n W,","year":"2006;","unstructured":"Chien\n W, \n \n Yin\n D, \n \n Gui\n D, \n et al\n . Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non\u2013small cell lung cancer cells. Mol Cancer Res. 2006;4(8):591\u2013598."},{"issue":"9","key":"i1543-2165-137-2-245-b18","series-title":"Clin Cancer Res","first-page":"2631","article-title":"Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer","volume":"14","author":"Alvarez\n H,","year":"2008;","unstructured":"Alvarez\n H, \n \n Corvalan\n A, \n \n Roa\n JC, \n et al\n . Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res. 2008;14(9):2631\u20132638."},{"key":"i1543-2165-137-2-245-b19","series-title":"AJCC Cancer Staging Manual. 7th ed","author":"Edge\n SB,","year":"2010","unstructured":"Edge\n SB, \n \n Byrd\n DR, \n \n Compton\n CC, \n \n Fritz\n AG, \n \n Greene\n FL, \n \n Trotti\n A. \n \n AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer;2010."},{"issue":"5","key":"i1543-2165-137-2-245-b20","series-title":"Ann Surg","first-page":"807","article-title":"Prognostic factors for gallbladder cancer in Japan","volume":"248","author":"Kayahara\n M,","year":"2008;","unstructured":"Kayahara\n M, \n \n Nagakawa\n T, \n \n Nakagawara\n H, \n \n Kitagawa\n H, \n \n Ohta\n T. \n \n Prognostic factors for gallbladder cancer in Japan. Ann Surg. 2008;248(5):807\u2013814."},{"issue":"6","key":"i1543-2165-137-2-245-b21","series-title":"Histol Histopathol","first-page":"795","article-title":"The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis","volume":"25","author":"Zuo\n GW,","year":"2010;","unstructured":"Zuo\n GW, \n \n Kohls\n CD, \n \n He\n BC, \n et al\n . The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol. 2010;25(6):795\u2013806."},{"issue":"1","key":"i1543-2165-137-2-245-b22","series-title":"Exp Oncol","first-page":"2","article-title":"The CCN family proteins in carcinogenesis","volume":"32","author":"Dhar\n A,","year":"2010;","unstructured":"Dhar\n A, \n \n Ray\n A. \n \n The CCN family proteins in carcinogenesis. Exp Oncol. 2010;32(1):2\u20139."},{"key":"i1543-2165-137-2-245-b23","series-title":"BMC Cancer","first-page":"291","article-title":"Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma","volume":"9","author":"Zhou\n ZQ,","year":"2009","unstructured":"Zhou\n ZQ, \n \n Cao\n WH, \n \n Xie\n JJ, \n \n et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer. 2009;9:291."},{"issue":"4","key":"i1543-2165-137-2-245-b24","series-title":"Endocr Relat Cancer","first-page":"781","article-title":"Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer","volume":"11","author":"Jiang\n WG,","year":"2004;","unstructured":"Jiang\n WG, \n \n Watkins\n G, \n \n Fodstad\n O, \n \n Douglas-Jones\n A, \n \n Mokbel\n K, \n \n Mansel\n RE. \n \n Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004;11(4):781\u2013791."},{"issue":"6","key":"i1543-2165-137-2-245-b25","series-title":"PLoS One","article-title":"Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer","volume":"2","author":"Chen\n PP,","year":"2007;","unstructured":"Chen\n PP, \n \n Li\n WJ, \n \n Wang\n Y, \n et al\n . Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One. 2007;2(6):e534."},{"issue":"4","key":"i1543-2165-137-2-245-b26","series-title":"Dig Liver Dis","first-page":"269","article-title":"Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma","volume":"37","author":"Gardini\n A,","year":"2005;","unstructured":"Gardini\n A, \n \n Corti\n B, \n \n Fiorentino\n M, \n et al\n . Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma. Dig Liver Dis. 2005;37(4):269\u2013274."},{"issue":"3","key":"i1543-2165-137-2-245-b27","series-title":"Biochimie","first-page":"377","article-title":"The CCN family: a new class of inflammation modulators?","volume":"93","author":"Kular\n L,","year":"2010;","unstructured":"Kular\n L, \n \n Pakradouni\n J, \n \n Kitabgi\n P, \n \n Laurent\n M, \n \n Martinerie\n C. \n \n The CCN family: a new class of inflammation modulators?\n Biochimie. 2010;93(3):377\u2013388."},{"issue":"2","key":"i1543-2165-137-2-245-b28","series-title":"CA Cancer J Clin","first-page":"69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld\n D,","year":"2006;","unstructured":"Schottenfeld\n D, \n \n Beebe-Dimmer\n J. \n \n Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56(2):69\u201383."},{"issue":"3","key":"i1543-2165-137-2-245-b29","series-title":"Langenbecks Arch Surg","first-page":"224","article-title":"Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones","volume":"386","author":"Tazuma\n S,","year":"2001;","unstructured":"Tazuma\n S, \n \n Kajiyama\n G. \n \n Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones. Langenbecks Arch Surg. 2001;386(3):224\u2013229."},{"issue":"9","key":"i1543-2165-137-2-245-b30","series-title":"Nat Rev Cancer","first-page":"695","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba, II,","year":"2004;","unstructured":"Wistuba, II, \n \n Gazdar\n AF. \n \n Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4(9):695\u2013706."},{"issue":"2","key":"i1543-2165-137-2-245-b31","series-title":"Oncol Rep","first-page":"327","article-title":"Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer","volume":"10","author":"Kitamura\n K,","year":"2003;","unstructured":"Kitamura\n K, \n \n Kasuya\n K, \n \n Tsuchida\n A, \n et al\n . Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer. Oncol Rep. 2003;10(2):327\u2013332."},{"issue":"3","key":"i1543-2165-137-2-245-b32","series-title":"Hepatobiliary Pancreat Dis Int","first-page":"448","article-title":"Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue","volume":"3","author":"Shi\n JS,","year":"2004;","unstructured":"Shi\n JS, \n \n Zhou\n LS, \n \n Han\n Y, \n \n Zhu\n AJ, \n \n Sun\n XJ, \n \n Yang\n YJ. \n \n Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int. 2004;3(3):448\u2013452."},{"issue":"12","key":"i1543-2165-137-2-245-b33","series-title":"J Clin Pathol","first-page":"1048","article-title":"Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis","volume":"63","author":"Kim\n H,","year":"2010;","unstructured":"Kim\n H, \n \n Song\n JY, \n \n Cho\n JY, \n et al\n . Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. J Clin Pathol. 2010;63(12):1048\u20131053."},{"issue":"4","key":"i1543-2165-137-2-245-b34","series-title":"Clin Cancer Res","first-page":"1157","article-title":"Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression","volume":"8","author":"Asano\n T,","year":"2002;","unstructured":"Asano\n T, \n \n Shoda\n J, \n \n Ueda\n T, \n et al\n . Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Clin Cancer Res. 2002;8(4):1157\u20131167."},{"issue":"3","key":"i1543-2165-137-2-245-b35","series-title":"Int J Cancer","first-page":"427","article-title":"Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder","volume":"98","author":"Kawamoto\n T,","year":"2002;","unstructured":"Kawamoto\n T, \n \n Shoda\n J, \n \n Asano\n T, \n et al\n . Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Int J Cancer. 2002;98(3):427\u2013434."},{"issue":"20","key":"i1543-2165-137-2-245-b36","series-title":"J Biol Chem","first-page":"15220","article-title":"Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts","volume":"275","author":"Abraham\n DJ,","year":"2000;","unstructured":"Abraham\n DJ, \n \n Shiwen\n X, \n \n Black\n CM, \n \n Sa\n S, \n \n Xu\n Y, \n \n Leask\n A. \n \n Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000;275(20):15220\u201315225."},{"issue":"2","key":"i1543-2165-137-2-245-b37","series-title":"Cytokine Growth Factor Rev","first-page":"133","article-title":"Regulation and function of connective tissue growth factor\/CCN2 in tissue repair, scarring and fibrosis","volume":"19","author":"Shi-Wen\n X,","year":"2008;","unstructured":"Shi-Wen\n X, \n \n Leask\n A, \n \n Abraham\n D. \n \n Regulation and function of connective tissue growth factor\/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008;19(2):133\u2013144."},{"issue":"8","key":"i1543-2165-137-2-245-b38","series-title":"World J Surg","first-page":"818","article-title":"Desmoplastic reaction influences pancreatic cancer growth behavior","volume":"28","author":"Hartel\n M,","year":"2004;","unstructured":"Hartel\n M, \n \n Di Mola\n FF, \n \n Gardini\n A, \n et al\n . Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg. 2004;28(8):818\u2013825."},{"issue":"10","key":"i1543-2165-137-2-245-b39","series-title":"Cell Signal","first-page":"1865","article-title":"Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells","volume":"20","author":"Karger\n A,","year":"2008;","unstructured":"Karger\n A, \n \n Fitzner\n B, \n \n Brock\n P, \n et al\n . Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal. 2008;20(10):1865\u20131872."},{"issue":"19","key":"i1543-2165-137-2-245-b40","series-title":"Cancer Res","first-page":"8887","article-title":"Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis","volume":"65","author":"Yang\n F,","year":"2005;","unstructured":"Yang\n F, \n \n Tuxhorn\n JA, \n \n Ressler\n SJ, \n \n McAlhany\n SJ, \n \n Dang\n TD, \n \n Rowley\n DR. \n \n Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19):8887\u20138895."},{"issue":"3","key":"i1543-2165-137-2-245-b01","series-title":"Eur J Surg Oncol","first-page":"306","article-title":"Gallbladder carcinoma","volume":"34","author":"Miller\n G,","year":"2008","unstructured":"Miller\n G, \n \n Jarnagin\n WR. \n \n Gallbladder carcinoma. Eur J Surg Oncol. 2008;34(3):306\u2013312."},{"issue":"7","key":"i1543-2165-137-2-245-b02","series-title":"Int J Cancer","first-page":"1591","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi\n G,","year":"2006;","unstructured":"Randi\n G, \n \n Franceschi\n S, \n \n La Vecchia\n C. \n \n Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591\u20131602."},{"issue":"8","key":"i1543-2165-137-2-245-b03","series-title":"Jpn J Clin Oncol","first-page":"992","article-title":"Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases","volume":"41","author":"Meng\n H,","year":"2011;","unstructured":"Meng\n H, \n \n Wang\n X, \n \n Fong\n Y, \n \n Wang\n ZH, \n \n Wang\n Y, \n \n Zhang\n ZT. \n \n Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992\u2013998."},{"issue":"2","key":"i1543-2165-137-2-245-b04","series-title":"World J Gastroenterol","first-page":"174","article-title":"Systematic review on the surgical treatment for T1 gallbladder cancer","volume":"17","author":"Lee\n SE,","year":"2011;","unstructured":"Lee\n SE, \n \n Jang\n JY, \n \n Lim\n CS, \n \n Kang\n MJ, \n \n Kim\n SW. \n \n Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17(2):174\u2013180."},{"issue":"105","key":"i1543-2165-137-2-245-b05","series-title":"Hepatogastroenterology","first-page":"14","article-title":"Optimal surgical treatment for patients with pT2 gallbladder cancer","volume":"58","author":"Harada\n K,","year":"2011;","unstructured":"Harada\n K, \n \n Ochiai\n T, \n \n Inoue\n K, \n et al\n . Optimal surgical treatment for patients with pT2 gallbladder cancer. Hepatogastroenterology. 2011;58(105):14\u201319."},{"issue":"4","key":"i1543-2165-137-2-245-b06","series-title":"Rev Med Chil","first-page":"387","article-title":"Morphological prognostic elements in gallbladder cancer [in Spanish]","volume":"130","author":"Roa\n I,","year":"2002;","unstructured":"Roa\n I, \n \n de Aretxabala\n X, \n \n Araya\n JC, \n et al\n . Morphological prognostic elements in gallbladder cancer [in Spanish]. Rev Med Chil. 2002;130(4):387\u2013395."},{"issue":"1","key":"i1543-2165-137-2-245-b07","series-title":"Eur J Surg Oncol","first-page":"80","article-title":"The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder","volume":"37","author":"Sergeant\n G,","year":"2011;","unstructured":"Sergeant\n G, \n \n Lerut\n E, \n \n Ectors\n N, \n \n Hendrickx\n T, \n \n Aerts\n R, \n \n Topal\n B. \n \n The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder. Eur J Surg Oncol. 2011;37(1):80\u201386."},{"issue":"8","key":"i1543-2165-137-2-245-b08","series-title":"Pathol Res Pract","first-page":"472","article-title":"Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma","volume":"207","author":"Liu\n DC,","year":"2011;","unstructured":"Liu\n DC, \n \n Yang\n ZL. \n \n Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol Res Pract. 2011;207(8):472\u2013478."},{"issue":"9","key":"i1543-2165-137-2-245-b09","series-title":"Clin Cancer Res","first-page":"3131","article-title":"Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival","volume":"10","author":"Varga\n M,","year":"2004;","unstructured":"Varga\n M, \n \n Obrist\n P, \n \n Schneeberger\n S, \n et al\n . Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res. 2004;10(9):3131\u20133136."},{"issue":"4","key":"i1543-2165-137-2-245-b10","series-title":"Int J Biochem Cell Biol","first-page":"771","article-title":"Functions and mechanisms of action of CCN matricellular proteins","volume":"41","author":"Chen\n CC,","year":"2009;","unstructured":"Chen\n CC, \n \n Lau\n LF. \n \n Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009;41(4):771\u2013783."},{"issue":"6","key":"i1543-2165-137-2-245-b11","series-title":"J Biomed Sci","first-page":"675","article-title":"Connective tissue growth factor (CTGF) and cancer progression","volume":"15","author":"Chu\n CY,","year":"2008;","unstructured":"Chu\n CY, \n \n Chang\n CC, \n \n Prakash\n E, \n \n Kuo\n ML. \n \n Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci. 2008;15(6):675\u2013685."},{"issue":"3","key":"i1543-2165-137-2-245-b12","series-title":"Cancer Res","first-page":"775","article-title":"The role of tumor cell\u2013derived connective tissue growth factor (CTGF\/CCN2) in pancreatic tumor growth","volume":"69","author":"Bennewith\n KL,","year":"2009;","unstructured":"Bennewith\n KL, \n \n Huang\n X, \n \n Ham\n CM, \n et al\n . The role of tumor cell\u2013derived connective tissue growth factor (CTGF\/CCN2) in pancreatic tumor growth. Cancer Res. 2009;69(3):775\u2013784."},{"issue":"1","key":"i1543-2165-137-2-245-b13","series-title":"Cancer Sci","first-page":"104","article-title":"Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-kappaB pathway","volume":"102","author":"Mao\n Z,","year":"2011;","unstructured":"Mao\n Z, \n \n Ma\n X, \n \n Rong\n Y, \n et al\n . Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-kappaB pathway. Cancer Sci. 2011;102(1):104\u2013110."},{"issue":"13","key":"i1543-2165-137-2-245-b14","series-title":"World J Gastroenterol","first-page":"2110","article-title":"Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer","volume":"14","author":"Liu\n LY,","year":"2008;","unstructured":"Liu\n LY, \n \n Han\n YC, \n \n Wu\n SH, \n \n Lv\n ZH. \n \n Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol. 2008;14(13):2110\u20132114."},{"issue":"1","key":"i1543-2165-137-2-245-b15","series-title":"Gastroenterology","first-page":"9","article-title":"Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer","volume":"128","author":"Lin\n BR,","year":"2005;","unstructured":"Lin\n BR, \n \n Chang\n CC, \n \n Che\n TF, \n et al\n . Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology. 2005;128(1):9\u201323."},{"issue":"5","key":"i1543-2165-137-2-245-b16","series-title":"J Natl Cancer Inst","first-page":"364","article-title":"Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis","volume":"96","author":"Chang\n CC,","year":"2004;","unstructured":"Chang\n CC, \n \n Shih\n JY, \n \n Jeng\n YM, \n et al\n . Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst. 2004;96(5):364\u2013375."},{"issue":"8","key":"i1543-2165-137-2-245-b17","series-title":"Mol Cancer Res","first-page":"591","article-title":"Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non\u2013small cell lung cancer cells","volume":"4","author":"Chien\n W,","year":"2006;","unstructured":"Chien\n W, \n \n Yin\n D, \n \n Gui\n D, \n et al\n . Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non\u2013small cell lung cancer cells. Mol Cancer Res. 2006;4(8):591\u2013598."},{"issue":"9","key":"i1543-2165-137-2-245-b18","series-title":"Clin Cancer Res","first-page":"2631","article-title":"Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer","volume":"14","author":"Alvarez\n H,","year":"2008;","unstructured":"Alvarez\n H, \n \n Corvalan\n A, \n \n Roa\n JC, \n et al\n . Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res. 2008;14(9):2631\u20132638."},{"key":"i1543-2165-137-2-245-b19","series-title":"AJCC Cancer Staging Manual. 7th ed","author":"Edge\n SB,","year":"2010","unstructured":"Edge\n SB, \n \n Byrd\n DR, \n \n Compton\n CC, \n \n Fritz\n AG, \n \n Greene\n FL, \n \n Trotti\n A. \n \n AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer;2010."},{"issue":"5","key":"i1543-2165-137-2-245-b20","series-title":"Ann Surg","first-page":"807","article-title":"Prognostic factors for gallbladder cancer in Japan","volume":"248","author":"Kayahara\n M,","year":"2008;","unstructured":"Kayahara\n M, \n \n Nagakawa\n T, \n \n Nakagawara\n H, \n \n Kitagawa\n H, \n \n Ohta\n T. \n \n Prognostic factors for gallbladder cancer in Japan. Ann Surg. 2008;248(5):807\u2013814."},{"issue":"6","key":"i1543-2165-137-2-245-b21","series-title":"Histol Histopathol","first-page":"795","article-title":"The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis","volume":"25","author":"Zuo\n GW,","year":"2010;","unstructured":"Zuo\n GW, \n \n Kohls\n CD, \n \n He\n BC, \n et al\n . The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol. 2010;25(6):795\u2013806."},{"issue":"1","key":"i1543-2165-137-2-245-b22","series-title":"Exp Oncol","first-page":"2","article-title":"The CCN family proteins in carcinogenesis","volume":"32","author":"Dhar\n A,","year":"2010;","unstructured":"Dhar\n A, \n \n Ray\n A. \n \n The CCN family proteins in carcinogenesis. Exp Oncol. 2010;32(1):2\u20139."},{"key":"i1543-2165-137-2-245-b23","series-title":"BMC Cancer","first-page":"291","article-title":"Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma","volume":"9","author":"Zhou\n ZQ,","year":"2009","unstructured":"Zhou\n ZQ, \n \n Cao\n WH, \n \n Xie\n JJ, \n \n et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer. 2009;9:291."},{"issue":"4","key":"i1543-2165-137-2-245-b24","series-title":"Endocr Relat Cancer","first-page":"781","article-title":"Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer","volume":"11","author":"Jiang\n WG,","year":"2004;","unstructured":"Jiang\n WG, \n \n Watkins\n G, \n \n Fodstad\n O, \n \n Douglas-Jones\n A, \n \n Mokbel\n K, \n \n Mansel\n RE. \n \n Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004;11(4):781\u2013791."},{"issue":"6","key":"i1543-2165-137-2-245-b25","series-title":"PLoS One","article-title":"Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer","volume":"2","author":"Chen\n PP,","year":"2007;","unstructured":"Chen\n PP, \n \n Li\n WJ, \n \n Wang\n Y, \n et al\n . Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One. 2007;2(6):e534."},{"issue":"4","key":"i1543-2165-137-2-245-b26","series-title":"Dig Liver Dis","first-page":"269","article-title":"Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma","volume":"37","author":"Gardini\n A,","year":"2005;","unstructured":"Gardini\n A, \n \n Corti\n B, \n \n Fiorentino\n M, \n et al\n . Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma. Dig Liver Dis. 2005;37(4):269\u2013274."},{"issue":"3","key":"i1543-2165-137-2-245-b27","series-title":"Biochimie","first-page":"377","article-title":"The CCN family: a new class of inflammation modulators?","volume":"93","author":"Kular\n L,","year":"2010;","unstructured":"Kular\n L, \n \n Pakradouni\n J, \n \n Kitabgi\n P, \n \n Laurent\n M, \n \n Martinerie\n C. \n \n The CCN family: a new class of inflammation modulators?\n Biochimie. 2010;93(3):377\u2013388."},{"issue":"2","key":"i1543-2165-137-2-245-b28","series-title":"CA Cancer J Clin","first-page":"69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld\n D,","year":"2006;","unstructured":"Schottenfeld\n D, \n \n Beebe-Dimmer\n J. \n \n Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56(2):69\u201383."},{"issue":"3","key":"i1543-2165-137-2-245-b29","series-title":"Langenbecks Arch Surg","first-page":"224","article-title":"Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones","volume":"386","author":"Tazuma\n S,","year":"2001;","unstructured":"Tazuma\n S, \n \n Kajiyama\n G. \n \n Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones. Langenbecks Arch Surg. 2001;386(3):224\u2013229."},{"issue":"9","key":"i1543-2165-137-2-245-b30","series-title":"Nat Rev Cancer","first-page":"695","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba, II,","year":"2004;","unstructured":"Wistuba, II, \n \n Gazdar\n AF. \n \n Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4(9):695\u2013706."},{"issue":"2","key":"i1543-2165-137-2-245-b31","series-title":"Oncol Rep","first-page":"327","article-title":"Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer","volume":"10","author":"Kitamura\n K,","year":"2003;","unstructured":"Kitamura\n K, \n \n Kasuya\n K, \n \n Tsuchida\n A, \n et al\n . Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer. Oncol Rep. 2003;10(2):327\u2013332."},{"issue":"3","key":"i1543-2165-137-2-245-b32","series-title":"Hepatobiliary Pancreat Dis Int","first-page":"448","article-title":"Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue","volume":"3","author":"Shi\n JS,","year":"2004;","unstructured":"Shi\n JS, \n \n Zhou\n LS, \n \n Han\n Y, \n \n Zhu\n AJ, \n \n Sun\n XJ, \n \n Yang\n YJ. \n \n Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int. 2004;3(3):448\u2013452."},{"issue":"12","key":"i1543-2165-137-2-245-b33","series-title":"J Clin Pathol","first-page":"1048","article-title":"Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis","volume":"63","author":"Kim\n H,","year":"2010;","unstructured":"Kim\n H, \n \n Song\n JY, \n \n Cho\n JY, \n et al\n . Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. J Clin Pathol. 2010;63(12):1048\u20131053."},{"issue":"4","key":"i1543-2165-137-2-245-b34","series-title":"Clin Cancer Res","first-page":"1157","article-title":"Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression","volume":"8","author":"Asano\n T,","year":"2002;","unstructured":"Asano\n T, \n \n Shoda\n J, \n \n Ueda\n T, \n et al\n . Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Clin Cancer Res. 2002;8(4):1157\u20131167."},{"issue":"3","key":"i1543-2165-137-2-245-b35","series-title":"Int J Cancer","first-page":"427","article-title":"Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder","volume":"98","author":"Kawamoto\n T,","year":"2002;","unstructured":"Kawamoto\n T, \n \n Shoda\n J, \n \n Asano\n T, \n et al\n . Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Int J Cancer. 2002;98(3):427\u2013434."},{"issue":"20","key":"i1543-2165-137-2-245-b36","series-title":"J Biol Chem","first-page":"15220","article-title":"Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts","volume":"275","author":"Abraham\n DJ,","year":"2000;","unstructured":"Abraham\n DJ, \n \n Shiwen\n X, \n \n Black\n CM, \n \n Sa\n S, \n \n Xu\n Y, \n \n Leask\n A. \n \n Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000;275(20):15220\u201315225."},{"issue":"2","key":"i1543-2165-137-2-245-b37","series-title":"Cytokine Growth Factor Rev","first-page":"133","article-title":"Regulation and function of connective tissue growth factor\/CCN2 in tissue repair, scarring and fibrosis","volume":"19","author":"Shi-Wen\n X,","year":"2008;","unstructured":"Shi-Wen\n X, \n \n Leask\n A, \n \n Abraham\n D. \n \n Regulation and function of connective tissue growth factor\/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008;19(2):133\u2013144."},{"issue":"8","key":"i1543-2165-137-2-245-b38","series-title":"World J Surg","first-page":"818","article-title":"Desmoplastic reaction influences pancreatic cancer growth behavior","volume":"28","author":"Hartel\n M,","year":"2004;","unstructured":"Hartel\n M, \n \n Di Mola\n FF, \n \n Gardini\n A, \n et al\n . Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg. 2004;28(8):818\u2013825."},{"issue":"10","key":"i1543-2165-137-2-245-b39","series-title":"Cell Signal","first-page":"1865","article-title":"Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells","volume":"20","author":"Karger\n A,","year":"2008;","unstructured":"Karger\n A, \n \n Fitzner\n B, \n \n Brock\n P, \n et al\n . Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal. 2008;20(10):1865\u20131872."},{"issue":"19","key":"i1543-2165-137-2-245-b40","series-title":"Cancer Res","first-page":"8887","article-title":"Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis","volume":"65","author":"Yang\n F,","year":"2005;","unstructured":"Yang\n F, \n \n Tuxhorn\n JA, \n \n Ressler\n SJ, \n \n McAlhany\n SJ, \n \n Dang\n TD, \n \n Rowley\n DR. \n \n Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19):8887\u20138895."}],"container-title":["Archives of Pathology & Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/137\/2\/article-p245.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/137\/2\/245\/1611823\/arpa_2011-0628-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/137\/2\/article-p245.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/137\/2\/article-p245.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:57:35Z","timestamp":1770771455000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/137\/2\/article-p245.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":80,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2011-0628-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}